The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 6th 2025
A rehabilitation method commonly used in patients who experience a traumatic brain injury was found to improve symptoms of long COVID, including brain fog and measures of daily living.
NCPA Backs New Senate Bill to End Retroactive 'DIR Fees,' Improve Medicare Transparency
September 12th 2016Four U.S. Senators today introduced bipartisan legislation to boost transparency in Medicare Part D drug spending and to prohibit retroactive "DIR fees" in response to concerns raised by National Community Pharmacists Association (NCPA) members and staff.
Read More
Blinatumomab Now Indicated for Children with Acute Lymphoblastic Leukemia
September 9th 2016The FDA has expanded the use of Amgen's blinatumomab (Blincyto) to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in pediatric patients.
Read More
A Closer Look at Hillary Clinton's Pharmaceutical Policy Proposals
September 9th 2016Although Democratic presidential candidate Hillary Clinton's prescription plan was released almost a year ago, the former Secretary of State's intentions for dealing with the pharmaceutical industry were back in the news last week.
Read More
DEA Intends to Make Kratom a Schedule I Controlled Substance
September 8th 2016The US Drug Enforcement Administration (DEA) is planning to place the active materials of the kratom plant under Schedule I of the Controlled Substances Act (CSA) in an effort to prevent a hazard to public safety.
Read More